Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 2/20 | 0.43 |
| ▸ | PAM | P19021 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PLAU | P00749 | 3/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL501799 | 0.96 | ALDH1A1 (0.57) | ALDH1A1MAPK1L3MBTL1CASP1PAM | |
| SCHEMBL501448 | 0.90 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1CASP1PAM | |
| SCHEMBL501844 | 0.78 | AKR1B1 (0.42) | ALDH1A1 | |
| SCHEMBL11852691 | 0.74 | ALDH1A1 (0.66) | ALDH1A1MAPK1L3MBTL1CASP1KMT2A | |
| SCHEMBL502353 | 0.74 | ELANE (0.52) | ALDH1A1MAPK1L3MBTL1KMT2APOLB | |
| SCHEMBL24464462 | 0.73 | ALDH1A1 (0.41) | ALDH1A1MAPK1L3MBTL1KMT2APOLB | |
| SCHEMBL31245908 | 0.72 | ALDH1A1 (0.85) | ALDH1A1MAPK1L3MBTL1CASP1PAM | |
| SCHEMBL16366728 | 0.72 | ALDH1A1 (0.62) | ALDH1A1MAPK1L3MBTL1PAMKMT2A | |
| SCHEMBL10204657 | 0.71 | ELANE (0.49) | ALDH1A1MAPK1L3MBTL1KMT2APOLB | |
| SCHEMBL361779 | 0.71 | ALDH1A1 (1.00) | ALDH1A1MAPK1L3MBTL1CASP1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044037-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | Gilead Sciences, Inc. (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008016522-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-02-07 | — | — | WO | disclosed |